Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-Lowering Therapy
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Pitavastatin (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics
- Acronyms PEACE
- 31 Aug 2018 Biomarkers information updated
- 03 Jul 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical information Network (Japan) record.
- 03 Jul 2012 Actual end date (1 Dec 2009) added as reported by University Hospital Medical information Network (Japan) record.